Tejas Savant
Stock Analyst at Morgan Stanley
(3.20)
# 1,151
Out of 5,072 analysts
241
Total ratings
47.06%
Success rate
0.98%
Average return
Main Sectors:
Stocks Rated by Tejas Savant
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCYT Veracyte | Maintains: Underweight | $28 → $40 | $47.37 | -15.56% | 14 | Nov 11, 2025 | |
| TEM Tempus AI | Maintains: Overweight | $68 → $80 | $77.93 | +2.66% | 5 | Nov 11, 2025 | |
| STVN Stevanato Group | Maintains: Equal-Weight | $24 → $26 | $23.36 | +11.30% | 2 | Nov 11, 2025 | |
| PSNL Personalis | Maintains: Equal-Weight | $5 → $9 | $10.73 | -16.12% | 13 | Nov 11, 2025 | |
| NTRA Natera | Maintains: Overweight | $195 → $220 | $238.81 | -7.88% | 14 | Nov 11, 2025 | |
| HOLX Hologic | Maintains: Equal-Weight | $69 → $76 | $74.96 | +1.39% | 11 | Nov 11, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Equal-Weight | $11 → $16 | $19.66 | -18.62% | 13 | Nov 11, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $560 → $656 | $590.83 | +11.03% | 15 | Oct 28, 2025 | |
| TXG 10x Genomics | Maintains: Overweight | $18 → $17 | $18.81 | -9.62% | 15 | Aug 12, 2025 | |
| ILMN Illumina | Maintains: Equal-Weight | $100 → $105 | $131.45 | -20.12% | 9 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $12 | $11.73 | +2.30% | 20 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $10 → $8 | $12.10 | -33.88% | 14 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $7 | $5.65 | +23.89% | 9 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $7 | $9.62 | -27.23% | 2 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $3.62 | +38.12% | 13 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $20 | $110.39 | -81.88% | 2 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $245 → $250 | $230.01 | +8.69% | 11 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $32 → $21 | $7.63 | +175.23% | 2 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $4 → $2 | $2.32 | -13.79% | 13 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $40 | $9.28 | +331.03% | 2 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $6 | $2.25 | +166.67% | 3 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $11 → $10 | $4.92 | +103.25% | 8 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $2.75 | $4.19 | -34.37% | 6 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $10 | $1.93 | +418.13% | 10 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $73 | $108.42 | -32.67% | 9 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $350 → $250 | $178.14 | +40.34% | 1 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $100 | $8.17 | +1,123.99% | 5 | May 12, 2022 |
Veracyte
Nov 11, 2025
Maintains: Underweight
Price Target: $28 → $40
Current: $47.37
Upside: -15.56%
Tempus AI
Nov 11, 2025
Maintains: Overweight
Price Target: $68 → $80
Current: $77.93
Upside: +2.66%
Stevanato Group
Nov 11, 2025
Maintains: Equal-Weight
Price Target: $24 → $26
Current: $23.36
Upside: +11.30%
Personalis
Nov 11, 2025
Maintains: Equal-Weight
Price Target: $5 → $9
Current: $10.73
Upside: -16.12%
Natera
Nov 11, 2025
Maintains: Overweight
Price Target: $195 → $220
Current: $238.81
Upside: -7.88%
Hologic
Nov 11, 2025
Maintains: Equal-Weight
Price Target: $69 → $76
Current: $74.96
Upside: +1.39%
Adaptive Biotechnologies
Nov 11, 2025
Maintains: Equal-Weight
Price Target: $11 → $16
Current: $19.66
Upside: -18.62%
Thermo Fisher Scientific
Oct 28, 2025
Maintains: Overweight
Price Target: $560 → $656
Current: $590.83
Upside: +11.03%
10x Genomics
Aug 12, 2025
Maintains: Overweight
Price Target: $18 → $17
Current: $18.81
Upside: -9.62%
Illumina
Aug 4, 2025
Maintains: Equal-Weight
Price Target: $100 → $105
Current: $131.45
Upside: -20.12%
Aug 4, 2025
Maintains: Equal-Weight
Price Target: $15 → $12
Current: $11.73
Upside: +2.30%
Jul 30, 2025
Maintains: Equal-Weight
Price Target: $10 → $8
Current: $12.10
Upside: -33.88%
May 28, 2025
Maintains: Equal-Weight
Price Target: $9 → $7
Current: $5.65
Upside: +23.89%
May 5, 2025
Maintains: Equal-Weight
Price Target: $8 → $7
Current: $9.62
Upside: -27.23%
Mar 25, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.62
Upside: +38.12%
Mar 18, 2025
Maintains: Equal-Weight
Price Target: $16 → $20
Current: $110.39
Upside: -81.88%
Feb 11, 2025
Maintains: Overweight
Price Target: $245 → $250
Current: $230.01
Upside: +8.69%
Nov 18, 2024
Maintains: Equal-Weight
Price Target: $32 → $21
Current: $7.63
Upside: +175.23%
Aug 12, 2024
Maintains: Equal-Weight
Price Target: $4 → $2
Current: $2.32
Upside: -13.79%
May 15, 2024
Maintains: Equal-Weight
Price Target: $80 → $40
Current: $9.28
Upside: +331.03%
Aug 3, 2023
Reiterates: Equal-Weight
Price Target: $6
Current: $2.25
Upside: +166.67%
May 10, 2023
Maintains: Overweight
Price Target: $11 → $10
Current: $4.92
Upside: +103.25%
Mar 7, 2023
Reiterates: Equal-Weight
Price Target: $2.75
Current: $4.19
Upside: -34.37%
Feb 21, 2023
Maintains: Equal-Weight
Price Target: $11 → $10
Current: $1.93
Upside: +418.13%
Feb 21, 2023
Maintains: Overweight
Price Target: $80 → $73
Current: $108.42
Upside: -32.67%
Aug 4, 2022
Downgrades: Equal-Weight
Price Target: $350 → $250
Current: $178.14
Upside: +40.34%
May 12, 2022
Maintains: Equal-Weight
Price Target: $140 → $100
Current: $8.17
Upside: +1,123.99%